Cardiff University begins study of schizophrenia therapy
The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor - News - PharmaTimes
Merthyr Tydfil United Kingdom Jennifer Swettenham Cardiff University Medicines Discovery Institute Cardiff University Cardiff University Brain Research Imaging Centre
Source: pharmatimes.com